Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed3
Recruiting1
Terminated1
Other3

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT02315599Enrolling By Invitation
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
Hematologic MalignanciesPediatric CancersSolid Tumors
PrincipalinvestigatorStart date: 2014-12-23
NCT00067821Completed
Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity
Brain Tumors
PrincipalinvestigatorStart date: 2014-02-11
NCT01660984Active Not Recruiting
Natural History Study of Children and Adults With Medullary Thyroid Cancer
Medullary Thyroid Cancer
PrincipalinvestigatorStart date: 2012-07-30
NCT01222754Phase 1Completed
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
Anaplastic AstrocytomaDiffuse Intrinsic Pontine GliomaHigh Grade Glioma
PrincipalinvestigatorStart date: 2010-11-23
NCT01445288Completed
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
Diffuse Intrinsic Pontine GliomaEpendymomaGerminoma+2 more
PrincipalinvestigatorStart date: 2006-12-05
NCT00923442Enrolling By Invitation
Biology Studies of Hematologic Cancers
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaHodgkins Lymphoma+2 more
PrincipalinvestigatorStart date: 2004-02-24

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinAnaplastic AstrocytomaDiffuse Intrinsic Pontine Glioma+3 more
Similarity Score8%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Brain NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteCarcinoma, Renal CellHodgkin Disease+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic Neoplasms+1 more
Similarity Score5%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteB-All

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-HodgkinSolid Tumors

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin Disease
Similarity Score4%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Gastrointestinal Stromal TumorsLymphoma, Non-HodgkinSolid Tumors
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT03165721Phase 2PrincipalInvestigator

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Carcinoma, Renal CellGastrointestinal Stromal TumorsParaganglioma+2 more
Terminated
NCT02315599PrincipalInvestigator

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

Hematologic MalignanciesPediatric CancersSolid Tumors
Enrolling By Invitation
NCT00067821PrincipalInvestigator

Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity

Brain Tumors
Completed
NCT01660984PrincipalInvestigator

Natural History Study of Children and Adults With Medullary Thyroid Cancer

Medullary Thyroid Cancer
Active Not Recruiting
NCT01222754Phase 1PrincipalInvestigator

Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas

Anaplastic AstrocytomaDiffuse Intrinsic Pontine GliomaHigh Grade Glioma
Completed
NCT01445288PrincipalInvestigator

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Diffuse Intrinsic Pontine GliomaEpendymomaGerminoma+2 more
Completed
NCT00923442PrincipalInvestigator

Biology Studies of Hematologic Cancers

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaHodgkins Lymphoma+2 more
Enrolling By Invitation
NCT07572136Phase 1PrincipalInvestigator

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Acute Lymphoblastic LeukemiaB-All
Recruiting

All 8 trials loaded